USPTO serial 79165535
RU
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- CARLSON, KRISTIN
- Law office
- TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical agents for ophthalmic use; pharmaceutical agents for treatment of otic and nasal disorders; pharmaceutical agents for the treatment of allergic symptoms; pharmaceutical agents for treatment of digestive organ disorders; pharmaceutical agents for the treatment of disorders of central nervous system; pharmaceutical agents for the treatment of cardiovascular diseases; hormones for medical and pharmaceutical purposes; pharmaceutical agents for treatment of urogenital and anal organ disorders; pharmaceutical preparations for skin care; pharmaceutical agents for treatment of dental and oral disorders; vitamin preparations; pharmaceutical agents for the treatment of blood or body fluid disorders; pharmaceutical agents for use in kidney dialysis treatments; pharmaceutical agents for the treatment of liver disorders; antidotes; pharmaceutical preparations for the treatment of alcohol, cigarette, and drug abuse; pharmaceutical preparations for the treatment of gout; enzyme preparations for medical use; pharmaceutical preparations for the treatment of diabetes; chondroitin preparations; adenosine preparations; lactagogues; pharmaceutical preparations for activating cellular functions; pharmaceutical preparations for the treatment of tumors; antibiotic preparations; chemotherapeutic agents; preparations for destroying parasites; pharmaceutical agents for use in the dispersal of medications within the body; diagnostic preparations for medical purposes; in vitro diagnostic preparations for medical purposes; alkaloidal narcotics for medical purposes; non- alkaloidal narcotics for medical purposes; chemical reagents for medical purposes | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 28, 2017 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Oct 27, 2017 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 21, 2017 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 8, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 8, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 11, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 26, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 26, 2016 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 8, 2016 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 8, 2016 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 15, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 28, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 28, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 28, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 27, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| May 30, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 26, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 22, 2015 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 21, 2015 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |